A critical breakthrough in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This crucial malignant protector protein is frequently lost in many forms of tumors, leading https://tinybookmarks.com/story21910433/mini-antibodies-reactivate-p53-a-new-approach-for-tumor-therapy